Şilte Karamanlioğlu Duygu, Aktas Ilknur, Ozkan Feyza Unlu, Kaysin Meryem, Girgin Nuray
Sultanbeyli State Hospital, Istanbul, Turkey.
Fatih Sultan Mehmet Education and Training Hospital, Istanbul, Turkey.
Rheumatol Int. 2016 May;36(5):653-61. doi: 10.1007/s00296-016-3441-3. Epub 2016 Feb 29.
The aim of our study was to evaluate effectiveness of ultrasound treatment applied with exercise therapy in patients with ankylosing spondylitis. Fifty-two patients, who were diagnosed according to modified New York criteria, were aged 25-60, and have spine pain, were randomly assigned to two groups. Ultrasound (US) and exercise therapy were applied to treatment group (27); placebo US treatment and exercise therapy were applied to control group (25). Patients were evaluated before treatment, at the end of treatment, and 4 weeks after the treatment. Daily and night pain, morning stiffness, patient global assessment (PGA), doctor global assessment (DGA), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire, Ankylosing Spondylitis Disease Activity Score (ASDAS) erythrocyte sedimentation rate (ESR), and ASDAS C-reactive protein (CRP) were used as clinical parameters. In US group, all parameters showed significant improvements at 2 and 6 weeks, in comparison with the baseline. In placebo US group, significant improvement was obtained for all parameters (except tragus-to-wall distance and modified Schober test at 2 weeks and lumbar side flexion and modified Schober test at 6 weeks). Comparison of the groups showed significantly superior results of US group for parameters of BASMI (p < 0.05), tragus-wall distance (p < 0.05), PGA (p < 0.01), and DGA (p < 0.05) at 2 weeks as well as for the parameters of daily pain (p < 0.01), PGA (p < 0.05), DGA (p < 0.01), BASDAI (p < 0.05), ASDAS-CRP (p < 0.05), ASDAS-ESR (p < 0.01), lumbar side flexion (p < 0.01), the modified Schober test (p < 0.01), and ASQoL (p < 0.05) at 6 weeks. Our study showed that ultrasound treatment increases the effect of exercise in patients with ankylosing spondylitis.
我们研究的目的是评估超声治疗联合运动疗法对强直性脊柱炎患者的疗效。52例根据改良纽约标准确诊、年龄在25至60岁之间且有脊柱疼痛的患者被随机分为两组。治疗组(27例)接受超声(US)和运动疗法;对照组(25例)接受安慰剂超声治疗和运动疗法。在治疗前、治疗结束时以及治疗后4周对患者进行评估。将日常和夜间疼痛、晨僵、患者整体评估(PGA)、医生整体评估(DGA)、巴斯强直性脊柱炎疾病活动指数(BASDAI)、巴斯强直性脊柱炎功能指数(BASFI)、巴斯强直性脊柱炎测量指数(BASMI)、强直性脊柱炎生活质量(ASQoL)问卷、强直性脊柱炎疾病活动评分(ASDAS)、红细胞沉降率(ESR)以及ASDAS C反应蛋白(CRP)作为临床参数。在美国组中,与基线相比,所有参数在2周和6周时均有显著改善。在安慰剂超声组中,所有参数(2周时的耳屏至胸壁距离和改良Schober试验以及6周时的腰椎侧屈和改良Schober试验除外)均有显著改善。两组比较显示,美国组在2周时BASMI参数(p < 0.05)、耳屏至胸壁距离(p < 0.05)、PGA(p < 0.01)和DGA(p < 0.05)以及在6周时日常疼痛参数(p < 0.01)、PGA(p < 0.05)、DGA(p < 0.01)、BASDAI(p < 0.05)、ASDAS-CRP(p < 0.05)、ASDAS-ESR(p < 0.01)、腰椎侧屈(p < 0.01)、改良Schober试验(p < 0.01)和ASQoL(p < 0.05)方面的结果明显更优。我们的研究表明,超声治疗可提高运动疗法对强直性脊柱炎患者的疗效。